Tom D. McCarthy

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial

Andrew S.C. Rice, Robert H. Dworkin, Tom D. McCarthy et al. · The Lancet · 2014 · 194 citations

Placebo-controlled Phase 2, Pain Syndrome, Health Sciences +10

Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity

David Tyssen, Scott Henderson, Adam Johnson et al. · PLoS ONE · 2010 · 171 citations · Full text

SPL7013 Gel as a Topical Microbicide for Prevention of Vaginal Transmission of SHIV _89.6P in Macaques

Yong-Hou Jiang, Peter Emau, J. Scott Cairns et al. · AIDS Research and Human Retroviruses · 2005 · 164 citations

Evaluations of Unformulated and FormulatedDendrimer-Based Microbicide Candidates in Mouse and Guinea PigModels of GenitalHerpes

David I. Bernstein, Lawrence R. Stanberry, Steven H. Sacks et al. · Antimicrobial Agents and Chemotherapy · 2003 · 118 citations · Full text

Nanomedicine, Medicinal Chemistry, Formulateddendrimer-based Microbicide Candidates +15

Preclinical Safety and Efficacy Assessments of Dendrimer-Based (SPL7013) Microbicide Gel Formulations in a Nonhuman Primate Model

Dorothy L. Patton, Yvonne Sweeney, Tom D. McCarthy et al. · Antimicrobial Agents and Chemotherapy · 2006 · 111 citations · Full text

Nonhuman Primate Model, Cervical Cancer, Gel Formulations +12